WASHINGTON (Reuters)—The U.S. House of Representatives on Friday passed a bill aimed at speeding new drugs to the market after lawmakers defeated last-minute amendments that threatened to derail it. The House voted 344 to 77 in favor of the bill, known as the 21st Century Cures Act, which would require the FDA to streamline the…
The ACR Partners with Coalition, Patient Advocacy Groups to Advocate for Rheumatology
In terms of getting our message heard in Washington, D.C., rheumatology faces a David vs. Goliath battle on several levels. Many industries have far greater resources, use multiple lobbying firms, and have advertising and lobbying budgets that eclipse ours by several hundred-fold. Rheumatology is far smaller than most other medical specialties; our membership is a…
Congressional Lawmakers Every Rheumatologist Should Know
Key leaders, committee members who can influence federal issues relevant to rheumatology
How to Engage Congress on Rheumatology Issues without Leaving Home
Ways to connect with Congressional leaders in their home districts
Congress Can Begin Work to Advance Rheumatology Before New Year
Medicare Advantage plans, specialty tier drug spending, SGR repeal, biomedical research funding issues on lawmakers’ plates
The ACR Seeks to Expand Engagement, Influence Among State Legislators
Members encouraged to advocate for rheumatology with elected officials in their home districts
Rheumatology Research Foundation Backs Need to Accelerate New Medicines for Lupus
Foundation appeals to Congressional lawmakers for support of biomedical innovation to battle lupus
American Medical Association House of Delegates Annual Meeting Update
AMA delegation chair Gary L. Bryant, MD, outlines AMA’s progress with ongoing initiatives, new resolutions submitted by the ACR
Advocate for Rheumatology Issues During Election Season
The ACR encourages members to meet with elected officials during Congress’ fall recess
The ACR’s Advocates for Arthritis Volunteers Meet with Congress
Access to rheumatology patient care, treatment, research funding on the agenda
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 12
- Next Page »